Uploaded December 2020 | Updated September 2026, 2 weeks ago
Last week I asked my longtime colleague, GV advisor Richard Scheller, for his perspective on the latest COVID-19 vaccine news. Richard has dedicated his life to developing new medicines, and as the leader of multiple R&D organizations, he pioneered oncology drugs that have helped millions of people. I was curious to get Richard's take on the development of the new COVID-19 vaccines, how quickly they might diffuse the pandemic, and what impact their accelerated development will have on future drug discovery and approval.
Read more: gv.com/news/richard-scheller-covid-19-vaccine
Last week I asked my longtime colleague, GV advisor Richard Scheller, for his perspective on the latest COVID-19 vaccine news. Richard has dedicated his life to developing new medicines, and as the leader of multiple R&D organizations, he pioneered oncology drugs that have helped millions of people. I was curious to get Richard's take on the development of the new COVID-19 vaccines, how quickly they might diffuse the pandemic, and what impact their accelerated development will have on future drug discovery and approval.
Read more: gv.com/news/richard-scheller-covid-19-vaccine
